Clinical Trials Logo

Self-Injurious Behavior clinical trials

View clinical trials related to Self-Injurious Behavior.

Filter by:

NCT ID: NCT03035110 Completed - Clinical trials for Self-Injurious Behavior

A Feasibility Study to Evaluate Self-Harm Group in Inpatient Settings

Start date: April 18, 2017
Phase: N/A
Study type: Interventional

The current research is being undertaken as part of a professional doctorate in clinical psychology, which aims to evaluate the feasibility of a group programme to address self-harm within 23 days, to provide evidence for a controlled trial. The intervention will include four group sessions conducted over 2 weeks, based on Dialectical Behavioural Therapy. Specifically the aims are to determine 1) means and a standard deviation for two pre and post treatment outcome measures in order to estimate sample size for the main study, 2) the need for an inpatient intervention for self-harm measured by number of participants eligible and accepting of the treatment, 3) retention of participants for 4 groups given the predicted short stays of patients on wards, and 4) the acceptability of the research process for this client group through feedback.

NCT ID: NCT03014362 Completed - Suicide Clinical Trials

TMS for Suicidal Crisis in Active Duty SMs

TMS4SI
Start date: June 12, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if the use of Transcranial Magnetic Stimulation (TMS) provides rapid reduction and sustained attenuation of suicidal crisis. TMS is a treatment for suicidal crisis that is quicker, less invasive, better tolerated, and with fewer side effects than current treatments such as Electroconvulsive Therapy (ECT) and medication therapies. There will be 6 months of follow-up, in order to establish the ongoing and lasting therapeutic effect of TMS.

NCT ID: NCT03008889 Completed - Clinical trials for Autism Spectrum Disorder

A Feasibility Study of N-acetylcysteine for Self-injurious Behavior in Children With Autism Spectrum Disorder

NAC
Start date: July 5, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to demonstrate the feasibility of a 9-week, randomized trial of N-acetylcysteine (NAC) compared to placebo in 14 children (age 5 to 12 years) with Autism Spectrum Disorder (ASD) and a moderate level of repetitive self-injurious behavior (SIB). Additional aims are to evaluate the positive predictive value of a screening method to classify children with automatically maintained self-injurious behavior; to evaluate the preliminary efficacy of NAC for reducing repetitive SIB in children with ASD; and to evaluate biomarkers and possible mechanisms of action of NAC in children with ASD.

NCT ID: NCT02988037 Completed - Clinical trials for Borderline Personality Disorder

Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study

Start date: September 2012
Phase: N/A
Study type: Interventional

The investigators conducted a pre-post naturalistic study regarding changes observed associated with a 15-week course of an adapted form of dialectical behaviour therapy for adolescents. We measured frequency of self-harm prior to treatment and after treatment using the Self-Injurious Thoughts and Behaviors Interview. We also measured changes using the Suicide Ideation Questionnaire, Life Problems Inventory, Resiliency Scale for Children and Adolescents.

NCT ID: NCT02985047 Completed - Suicidal Ideation Clinical Trials

Brief Admission Skane: Replacing General Admission for Individuals With Self-harm and Acute Risk of Suicide

BAS
Start date: September 1, 2015
Phase: N/A
Study type: Interventional

The purpose of the study is to test a standardized version of brief admission (BA) through randomized controlled trial (RCT). The main objective is to evaluate if BA can serve as a crisis management model for individuals with recurrent self-harm, including suicide attempts and at least three symptoms of Borderline Personality disorder. Participants will be allocated to BA + Treatment as Usual (TAU) or TAU.

NCT ID: NCT02771886 Completed - Substance Use Clinical Trials

Evaluation of a Brief Surf the Urge Intervention

SUBMI
Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of a brief "Surf the Urge" intervention to reduce adolescent and young adult (i.e., 14 to 24 years old) urge-related behaviors. These behaviors will include, but not be limited to, substance use, deliberate self-harm, aggressive behavior, pulling out hair, and loosing control when eating.The intervention will utilize mindfulness skills (i.e., awareness, acceptance, nonjudgment) to assist in reducing these risky behaviors.

NCT ID: NCT02771691 Completed - Clinical trials for Deliberate Self-Harm

Mentalization-Based Group Therapy for Adolescents

Start date: February 2016
Phase: N/A
Study type: Interventional

This is a prospective parallel group design of group-based Mentalization-Based Therapy for Adolescents (MBT-A) through a pilot randomised controlled trial comparing group-based MBT-A plus treatment as usual (TAU) to TAU alone. As a pilot study, we aim to determine: the effectiveness of our recruitment strategies; compliance with protocol/procedures; trends towards reduced self-harm.

NCT ID: NCT02742922 Completed - Self Harm Clinical Trials

Multicenter Study to Evaluate the Clinical and Cost-effectiveness of a Culturally Adapted Therapy (C-MAP)

C-MAP
Start date: April 27, 2016
Phase: N/A
Study type: Interventional

To evaluate the clinical and cost-effectiveness of a culturally adapted therapy (C-MAP) in patients with a history of self-harm

NCT ID: NCT02697019 Completed - Clinical trials for Nonsuicidal Self-Injury

Internet-delivered Emotion Regulation Individual Therapy for Adolescents With NSSI - An Open Pilot Study

Start date: February 2016
Phase: N/A
Study type: Interventional

The primary aim is to investigate the effectiveness of an Internet-delivered Emotion Regulation Individual Therapy for Adolescents (ERITA) with nonsuicidal self-injury (NSSI).

NCT ID: NCT02638974 Completed - Clinical trials for Self Injurious Behaviour

Skin Camouflage for Women Prisoners With Self-Harm Scarring

COVER
Start date: February 29, 2016
Phase: N/A
Study type: Interventional

Women prisoners are more likely to commit suicide or self-harm than women in the community or male prisoners. Healthcare services have improved how they manage self-harm in the community and prisons. However, there has been little focus on the recovery of people with self-harm scars. Medical skin camouflage (MSC) is a British National Formulary-listed topical cream designed to cover skin conditions. Research on MSC has focused on its use with non-self-harm marks e.g. burns. The evidence from this research suggests that the cream helps women feel better and do more activities. There is little/no evidence about the effects of the preparation for women who self-harm and for prisoners. This research was funded by the National Institute for Health Research Research for Patient Benefit Programme. In the research the investigators will examine whether it is possible and practical to use MSC in prison. The investigators will ask women prisoners and staff what they think about the cream. The research has four parts. In the first part the investigators will run focus groups with women prisoners and prison staff to find out the best way to deliver the MSC intervention and how to measure its effects. In the second part the investigators will design a programme for delivering the MSC. The investigators will then train 6-10 long-term prisoners to become skin camouflage practitioners. The final part will involve a small randomised controlled trial with 40 women prisoners; 20 will be allocated to the intervention group and will use the MSC for 6 weeks. The investigators will measure their mood, thoughts of self-harm and wellbeing before and after they use MSC. The investigators will compare these results with 20 women who have not used MSC (waitlist control group). All women taking part will be placed at random into the control or the treatment group. The control group will receive the MSC after the research has ended. Potential benefits of this study may be an increase in self-esteem and quality of life for the women prisoners. As women recover they may be less likely to self-harm.